Nyt fra tidsskrifterne
Søgeord (paxlovid) valgt.
14 emner vises.
1
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
BMC Infectious Diseases
Tilføjet 1.03.2025
2
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
BMC Infectious Diseases
Tilføjet 27.02.2025
3
Independent FDA Analyses of Nirmatrelvir/Ritonavir Resistance in the Phase 2/3 Trials EPIC-HR and EPIC-SR
Clinical Infectious Diseases
Tilføjet 18.12.2024
4
D-dimer for efficacy prediction in COVID-19 patients treated with paxlovid
BMC Infectious Diseases
Tilføjet 26.11.2024
5
Who Needs Paxlovid in 2024?
Journal of the American Medical Association
Tilføjet 6.10.2024
6
Paxlovid reduces the 28-day mortality of patients with COVID-19: a retrospective cohort study
BMC Infectious Diseases
Tilføjet 6.08.2024
7
What the Latest Research Says About Paxlovid
Journal of the American Medical Association
Tilføjet 21.02.2024
8
Does Paxlovid Prevent Long COVID?
Journal of the American Medical Association
Tilføjet 12.01.2024
9
Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients
BMC Infectious Diseases
Tilføjet 4.01.2024
10
Appraisal of evidence reliability and applicability of Paxlovid as treatment for SARS‐COV‐2 infection: A systematic review
Reviews in Medical Virology
Tilføjet 11.11.2023
11
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis
Reviews in Medical Virology
Tilføjet 8.09.2023
12
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
Clinical & Experimental Immunology
Tilføjet 11.08.2023
13
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
BMJ Open
Tilføjet 8.08.2023
14
Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge
Journal of Medical Virology
Tilføjet 1.08.2023